Back to Aberdeen Group plc Aberdeen Group plc

MYGNMYGN
5 quarters

Position history for Aberdeen Group plcAberdeen Group plc's holdings in MYRIAD GENETICS INC

Aberdeen Group plc holds 1.3M shares of MYGN (MYRIAD GENETICS INC), worth $7.5M as of 2026-Q2. The position was increased (+17.9% shares). MYGN represents 0.0% of Aberdeen Group plc's portfolio.

Current Value

$7.5M

Current Shares

1.3M

Total Value Change

+$6.3M

Total Shares Change

+1.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.3M
+17.9%
$7.5M0.0%$5.71
32
2026-Q1
Increased
1.1M
+25.4%
$5M0.0%$5.29
33
2025-Q4
Increased
885,801
+38.6%
$5.4M0.0%$6.17
36
2025-Q3
Increased
639,053
+178.3%
$4.6M0.0%$7.24
43
2025-Q2
New
229,593
-
$1.2M0.0%$5.25
35

Other major holders of MYGN: BNP PARIBAS FINANCIAL MARKETS, BlackRock Finance, Inc., BAILLIE GIFFORD & CO, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used